| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2481108C Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/28/2013 | CA2477734C Suramin and derivatives thereof as topical microbicide and contraceptive |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2473970C Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2459367C Methods for construction and screening of libraries of chemokine variants |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2427661C Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/28/2013 | CA2222455C A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 05/23/2013 | WO2013074794A1 Latent human immunodeficiency virus reactivation |
| 05/23/2013 | WO2013074489A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | WO2013073875A1 Novel antiviral pyrrolopyridine derivative and a production method for same |
| 05/23/2013 | WO2013073827A1 Composition containing natural minerals and the water extracted therefrom as active ingredients |
| 05/23/2013 | WO2013073545A1 Medicine for treatment and/or improvement of sepsis |
| 05/23/2013 | WO2013072946A1 Lactoferrin derived peptides for use as broad- spectrum inhibitors of influenza virus infection |
| 05/23/2013 | WO2013072903A1 Nitroimidazoxadiazocine compounds |
| 05/23/2013 | WO2013072882A1 2 -amino- 1, 8 -naphthyridine-3 -carboxamide derivatives as antimicrobial agents |
| 05/23/2013 | WO2013072703A1 Antibacterial drug derivatives |
| 05/23/2013 | WO2013072542A1 Adjuvant effect of the vaccinia virus a27 protein (14k) and the use thereof in vaccines |
| 05/23/2013 | WO2013072518A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation |
| 05/23/2013 | WO2013072514A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | WO2013072513A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation |
| 05/23/2013 | WO2013072512A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | WO2013072511A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072510A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | WO2013072355A1 Mannosylated compounds useful for the prevention and the treatment of infectious diseases |
| 05/23/2013 | WO2013071724A1 Baicalin metal complex and preparation method and application thereof |
| 05/23/2013 | WO2013071723A1 Preparation method of antibacterial lipopeptide and application thereof to veterinary medicine |
| 05/23/2013 | WO2013071409A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | WO2013071353A1 Apricitabine and pi combination therapy |
| 05/23/2013 | WO2013049382A3 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| 05/23/2013 | WO2013048130A3 Binding molecule for neutralizing rabies virus |
| 05/23/2013 | WO2013042140A3 Non antibiotic,non peptide compounds for antibiotic efficacy & safety enhancement |
| 05/23/2013 | WO2013037487A8 A particulate system for use in diminishing cell growth/inducing cell killing |
| 05/23/2013 | WO2013021260A3 Compounds from anisomeles heyneana |
| 05/23/2013 | WO2013015586A3 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 05/23/2013 | WO2012165854A9 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 05/23/2013 | WO2012095793A3 (n-alkylcarbamoyl) methyl enulosides and related pyranoside containing an alfa, beta, gama, delta - unsaturated ester, their preparation and their efficacy as antibacterial agents |
| 05/23/2013 | WO2011119047A8 Carvacrol/thymol composition for the treatment of salmonid rickettsial septicemia and infectious salmon anemia |
| 05/23/2013 | US20130129808 Medical product containing active component of propolis or grapefruit seed extract and manufacturing method thereof |
| 05/23/2013 | US20130129697 Enhanced Staphylolytic Activity of the Staphylococcus aureus Bacteriophage vB_SauS-philPLA88 Virion-Associated Peptidoglycan Hydrolase HydH5: Fusions, Deletions and Synergy with LysH5 |
| 05/23/2013 | US20130129680 Method for treating hepatitis c virus infection using quercetin-containing compositions |
| 05/23/2013 | US20130129659 Composite enterosorbent |
| 05/23/2013 | US20130129639 Cassia Derivatives |
| 05/23/2013 | CA2856154A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute_condition |
| 05/23/2013 | CA2856150A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease |
| 05/23/2013 | CA2856142A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizingthe circulation |
| 05/23/2013 | CA2856141A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy |
| 05/23/2013 | CA2856136A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/23/2013 | CA2856085A1 Clostridium difficile lipoteichoic acid and uses thereof |
| 05/23/2013 | CA2855797A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation |
| 05/23/2013 | CA2855675A1 Conjugates of gm-csf and il-7, compositions and methods related thereto |
| 05/23/2013 | CA2854946A1 Apricitabine and pi combination therapy |
| 05/23/2013 | CA2854882A1 Medicament for therapeutic treatment and/or improvement of sepsis |
| 05/23/2013 | CA2815082A1 Antiviral compounds |
| 05/22/2013 | EP2594588A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or an anti-ADM non-Ig scaffold for use in therapy |
| 05/22/2013 | EP2594587A1 Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| 05/22/2013 | EP2594585A1 Methods of treating pain and inflammation in neuronal tissue using IL-31 antagonists |
| 05/22/2013 | EP2594579A1 Truncated human papillomavirus type 58 l1 protein |
| 05/22/2013 | EP2594575A1 Mannosylated compounds useful for the prevention and the treatment of infectious diseases |
| 05/22/2013 | EP2594283A1 Aprotinin-based aerosol preparation for the treatment of viral respiratory infections |
| 05/22/2013 | EP2593548A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 05/22/2013 | EP2593460A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| 05/22/2013 | EP2593439A2 Process for preparing antiviral compounds |
| 05/22/2013 | EP2593430A1 Derivatives of 1,4-dihydropyridine possessing antiviral efficacy |
| 05/22/2013 | EP2593187A2 Methods and compositions including spore-forming bacteria for increasing the health of animals |
| 05/22/2013 | EP2593141A2 Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
| 05/22/2013 | EP2593120A1 Method of treatment of hiv or aids |
| 05/22/2013 | EP2593112A2 Novel antibacterial compounds, methods of making them, and uses thereof |
| 05/22/2013 | EP2593105A1 Palatable pharmaceutical composition comprising vx-950 |
| 05/22/2013 | EP2593103A2 Reducing transmission of sexually transmitted infections |
| 05/22/2013 | EP2592935A2 Disinfectant and antiseptic formulation having reduced iodine content |
| 05/22/2013 | CN1652754B Tasted masked veterinary solid compositions |
| 05/22/2013 | CN103119168A Human papillomavirus E7 antigen compositions and uses thereof |
| 05/22/2013 | CN103119066A Compound having activity for inhibiting tgf- belta receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103118702A Therapeutic vaccination against active tuberculosis |
| 05/22/2013 | CN103118682A Uses of phospholipid conjugates of synthetic TLR7 agonists |
| 05/22/2013 | CN103118681A Solid compositions |
| 05/22/2013 | CN103118670A Nanoparticulate composition containing antibiotics for intramammary administration in animals |
| 05/22/2013 | CN103114105A Method for preparing TGEV (Transmissible Gastroenteritis Virus)-S gene corns |
| 05/22/2013 | CN103114046A Aspergillus tubingensis SZX-6 and fermentation liquid, fermentation liquid extract and application thereof |
| 05/22/2013 | CN103113466A Recombinant human interferon beta-1b modified by polyethylene glycol and preparation method of recombinant human interferon beta-1b |
| 05/22/2013 | CN103113465A Interferon-alpha mutant and polyethylene glycol derivative thereof |
| 05/22/2013 | CN103113461A Novel defensin BD2, and gene and application thereof |
| 05/22/2013 | CN103113458A Hepatitis c virus B-cell epitope peptide PUHI34 and application thereof |
| 05/22/2013 | CN103113390A Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium |
| 05/22/2013 | CN103113382A Group of sesquiterpenoid coumarin and sesquiterpenoid chromone compounds |
| 05/22/2013 | CN103113371A Acyclovir eutectic and preparation method thereof and preparation |
| 05/22/2013 | CN103113310A Thiouracil derivative and application thereof |
| 05/22/2013 | CN103113295A Alkyl-substituted quinolinone compound with side chains as well as preparation method, pharmaceutical composition and application thereof |
| 05/22/2013 | CN103113285A Indole compound and application thereof as HIV-1 reverse transcriptase inhibitor |
| 05/22/2013 | CN103113276A Dithiobiurea derivative and application thereof |
| 05/22/2013 | CN103113275A Double-phenyl thiourea derivative and application thereof |